April 19, 2021

Lonnie Listonsmith

Experienced Health Expert

Precision

1 min read

News Release

Thursday, March 18, 2021

What

COVID-19 puts renewed focus on the urgent need to put diverse health data to work to support new discoveries and bring more precise prevention and treatment strategies to communities. A new commentary in Cell, co-authored by Director of the National Institutes of Health Francis S. Collins, M.D., Ph.D., and Joshua C. Denny, M.D., M.S., chief executive officer of the All of Us Research Program, highlights seven opportunities to accelerate tailored medicine efforts and create a more equitable health landscape in the future.

The commentary covers key areas including huge cohorts, artificial

Read More
1 min read

The precise choice of treatment for breast cancer depends upon the status of the hormone receptors (for oestrogen and progesterone). Their conventional determination by means of immunohistochemistry (IHC) is associated with a certain error rate, which can be reduced by adding genomic data. Even conventional statistics can bring about a notable improvement but now it is possible to use decision theory to optimally combine diagnostic findings, particularly where they are contradictory. This is the finding of a recent study conducted by MedUni Vienna under the leadership of Wolfgang Schreiner from the Center for Medical Statistics, Informatics and Intelligent Systems (CeMSIIS).

Read More
1 min read

Reston, Virginia–Physicians who follow artificial intelligence (AI) advice may be considered less liable for medical malpractice than is commonly thought, according to a new study of potential jury candidates in the U.S. Published in the January issue of The Journal of Nuclear Medicine (JNM). The study provides the first data related to physicians’ potential liability for using AI in personalized medicine, which can often deviate from standard care.

“New AI tools can assist physicians in treatment recommendations and diagnostics, including the interpretation of medical images,” remarked Kevin Tobia, JD, PhD, assistant professor of law at the Georgetown University Law Center,

Read More
1 min read

IRVING, Texas–(Business Wire)–

McKesson, a global leader in healthcare committed to transforming cancer research, has joined together with life sciences companies, oncology providers and patient advocacy groups in a unique collaborative effort, titled MYLUNG, to advance precision medicine options for non-small cell lung cancer (NSCLC) patients who are being treated in the community. NSCLC is the most common type of lung cancer according to the American Cancer Society, accounting for about 84% of lung cancer cases.

The MYLUNG consortium – or “Molecularly Informed Lung Cancer Treatment in a Community Cancer N

Read More
1 min read
  • Investment will bring Canada’s first centre of manufacturing excellence of nanomedicine-based RNA vaccines, gene therapies and cell therapies.
  • At project completion early in 2023, the approximately 40,000 square foot leased bio-manufacturing facility will have multiple GMP suites with manufacturing lines for the end-to-end manufacturing of genetic medicines.
  • The contribution is being made through the Government of Canada’s Strategic Innovation Fund , a program designed to attract and support high-quality business investments across all sectors of the economy.

VANCOUVER, BC, Feb. 2, 2021 /PRNewswire/ – Precision NanoSystems, Inc. (PNI), a global leader in technologies and solutions for development of genetic medicines,

Read More
lonnielistonsmith.net© All rights reserved. | Newsphere by AF themes.